90 related articles for article (PubMed ID: 6314868)
1. Retinoic acid binding protein in human and experimental pancreatic carcinomas in hamsters.
Brandes M; Gesell MS; Ueda H; Millan JC; Quinlan RM; Ernst C; Sindelar WF; Kurman CC; Harris S; Brandes D
Ann Clin Lab Sci; 1983; 13(5):400-6. PubMed ID: 6314868
[TBL] [Abstract][Full Text] [Related]
2. A Mr 58,000 glycoprotein specifically expressed in developing hamster pancreas and reexpressed in hamster and human pancreatic carcinomas.
Heredia A; Escribano MJ
Cancer Res; 1988 Dec; 48(23):6906-11. PubMed ID: 3180099
[TBL] [Abstract][Full Text] [Related]
3. Transplantable ductal adenocarcinoma of the Syrian hamster pancreas.
Scarpelli DG; Rao MS
Cancer Res; 1979 Feb; 39(2 Pt 1):452-8. PubMed ID: 216489
[TBL] [Abstract][Full Text] [Related]
4. Fibrin deposition in autochthonous Syrian hamster pancreatic adenocarcinomas induced by the chemical carcinogen N-nitroso-bis(2-oxopropyl)amine.
Brown LF; Chester JF; Malt RA; Dvorak HF
J Natl Cancer Inst; 1987 May; 78(5):979-86. PubMed ID: 3553693
[TBL] [Abstract][Full Text] [Related]
5. Fetal pancreatic antigens in the Syrian golden hamster and their relationship to development and carcinogenesis.
Benedi VJ; Escribano MJ; Zuinghedau J; Burtin P
Cancer Res; 1984 Mar; 44(3):1135-41. PubMed ID: 6362857
[TBL] [Abstract][Full Text] [Related]
6. Diabetes enhances growth of pancreatic carcinoma cells.
Fisher WE; McCullough PJ; Ray MB; Rogers DH; Bell RH
Surgery; 1988 Aug; 104(2):431-6. PubMed ID: 3400068
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
[TBL] [Abstract][Full Text] [Related]
8. A protein cross-reacting immunohistochemically with rat glutathione S-transferase placental form as a marker for preneoplasia in Syrian hamster pancreatic and hepatocarcinogenesis.
Moore MA; Satoh K; Kitahara A; Sato K; Ito N
Jpn J Cancer Res; 1985 Jan; 76(1):1-4. PubMed ID: 3918905
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic retinoic acid binding protein in the human pancreas.
Jutley JK; Kelleher J; Brennan TG; Denyer ME; Mitchell CJ
Gut; 1988 Aug; 29(8):1093-7. PubMed ID: 2842235
[TBL] [Abstract][Full Text] [Related]
10. Cellular retinoic acid-binding protein in human lung carcinomas.
Clamon GH; Nugent KM; Rossi NP
J Natl Cancer Inst; 1981 Jul; 67(1):61-3. PubMed ID: 6265683
[TBL] [Abstract][Full Text] [Related]
11. Role of cellular retinoic acid binding protein (cRABP) in patients with large bowel cancer.
Di Fronzo G; Cappelletti V; Miodini P; Bertario L; Ravasi G
Cancer Detect Prev; 1987; 10(5-6):327-33. PubMed ID: 3032437
[TBL] [Abstract][Full Text] [Related]
12. Temporal distribution of retinoic acid and cellular retinoic acid-binding protein (CRABP) in the fetal hamster.
Hatori A; Shigematsu A; McCormick AM; Willhite CC; Sharma RP
Exp Mol Pathol; 1991 Aug; 55(1):38-54. PubMed ID: 1653151
[TBL] [Abstract][Full Text] [Related]
13. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine.
Kokkinakis DM; Albores-Saavedra J
Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the level of cellular retinoid-binding proteins and susceptibility to retinoid-induced growth inhibition of various neoplastic cell lines.
Lotan R; Ong DE; Chytil F
J Natl Cancer Inst; 1980 May; 64(5):1259-62. PubMed ID: 6929023
[TBL] [Abstract][Full Text] [Related]
15. Different pattern of metastasis in liver implanted pancreatic cancer between young and old Syrian golden hamsters.
Morioka CY; Saito S; Machado MC; Jukemura J; Bacchella T; Watanabe A
In Vivo; 2005; 19(3):639-41. PubMed ID: 15875787
[TBL] [Abstract][Full Text] [Related]
16. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
17. Novel assay for pancreatic cellular damage: 1. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein.
Pousette A; Fernstad R; Sköldefors H; Carlström K
Pancreas; 1988; 3(4):421-6. PubMed ID: 2459692
[TBL] [Abstract][Full Text] [Related]
18. Relationship between alphaGal epitope expression and decrease of tumorigenicity in pancreatic adenocarcinoma model.
Aubert M; Crotte C; Benkoel L; Panicot-Dubois L; Bernard JP; Lombardo D; Sadoulet MO; Mas E
Mol Carcinog; 2005 Apr; 42(4):202-12. PubMed ID: 15761838
[TBL] [Abstract][Full Text] [Related]
19. Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma.
Chang KW; Mangold KA; Hubchak S; Laconi S; Scarpelli DG
Cancer Res; 1994 Jul; 54(14):3878-83. PubMed ID: 8033110
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of carcinogenesis by N-nitrosobis(2-oxopropyl)amine administered during S phase of the cell cycle in regenerating hamster pancreas.
Scarpelli DG; Rao MS; Subbarao V
Cancer Res; 1983 Feb; 43(2):611-6. PubMed ID: 6848182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
